News & Events

Upcoming events

27 to 28 September 2021

FIGON Dutch Medicines Days 2021

Leiden, Stadsgehoorzaal
10 to 10 November 2021

CGB-MEB Collegedag 2021

23 November 2021

RSNN annual workshop 2021

Jaarbeurs Utrecht


08 March 2019

Looking back and looking forward

In 2018, RSNN further expanded its network and activities. 2019 promises to be an exciting year in which RSNN activities will expand further, with an...

Read more
27 December 2018

RSNN Newsletter 6: December 2018

With the sixth edition of the RSNN newsletter, a new look is introduced. In this edition, we report on the RSNN sessions during the FIGON Dutch Medicines...

Read more
13 December 2018

A forum for discussion: "The emergence of regulatory science gave us the opportunity to reach out to others"

Christine Gispen-de Wied is stepping down as Vice-Chair of the RSNN, after three years in the role. She shared her thoughts on what regulatory science has...

Read more
28 November 2018

Regulatory challenges for the next wave of cancer therapies

In the RSNN morning session of the FIGON Dutch Medicines Days speakers from different perspectives presented their views on the challenges that come with...

Read more
28 November 2018

Evidence generation for innovative products in oncology

In the RSNN afternoon session of the FIGON Dutch Medicines Days, future evidence generation strategies were discussed.

Read more
28 November 2018

Focus on paediatric medicines in 6th edition of MEB’s Regulatory Science Magazine

Last week, the Medicines Evaluation Board (MEB) launched its 6th edition of the Regulatory Science Magazine.

Read more
09 November 2018

RSNN at EMA ‘Regulatory Science to 2025’ stakeholder consultation

To advance its engagement with regulatory science, the EMA gathered insights from stakeholders during a workshop on October 24.

Read more
08 November 2018

Looking back: Regulatory Science at the Partnerships MeetUp 2018

Regulatory science was an important topic during the Partnerships MeetUp on November 1st.

Read more
10 October 2018

Early stage cooperation between patients, developers, regulators and HTA bodies is critical for success in cancer treatment development

Read more
01 September 2018

RSNN Newsletter 5: September 2018

The fifth RSNN newsletter is out now! In this edition we report on the RSNN Workshop ‘What’s in, What’s out, What’s relevant? – Towards a sensible label’...

Read more
18 July 2018

Adaptive Pathways in Nature Reviews Drug Discovery

Earlier this month, Nature Reviews Drug Discovery (NRDD) published an article about Medicines Adaptive Pathways to Patients' (MAPPs). MAPPs seek to foster...

Read more
01 December 2017

RSNN Newsletter 4: Winter 2017

In this edition, we report on the Regulatory Science session on disease interception (BOX 3) held at the FIGON Dutch Medicines Days on October 2, 2017. In...

Read more